Work

Conservative Pharmacological Treatment of Central Giant Cell Lesion: an Integrative Review

Year: 2026
Type: preprint
Abstract: INTRODUCTION: Central Giant Cell Lesion (CGCL) is a benign intraosseous lesion with variable and potentially aggressive clinical behavior. It may cause root resorption, tooth displacement, occlusal disturbances, pain, and facial asymmetry. Although surgical treatment remains the conventional approach, it may be associated with morbidity, esthetic-functional defects, and recurrence. In this context, conservative pharmacological therapies have been employed as primary, adjuvant, or neoadjuvant approaches. OBJECTIVE(S): To analyze the main conservative pharmacological therapies used in the management of CGCL, discussing their clinical indications, limitations, adverse effects, and role in relation to surgery. METHODOLOGY: This is a descriptive integrative review guided by a research question structured according to the PICO strategy. Conservative pharmacological therapies applied to CGCL and their therapeutic outcomes were investigated, including clinical-radiographic response, safety, recurrence, and the need for additional surgery. Searches were conducted in PubMed/MEDLINE, LILACS, Scopus, and Web of Science databases, including studies available up to 2026. Records were organized in Rayyan, with duplicate removal and screening according to PRISMA recommendations. RESULTS: The literature shows that surgery remains the standard treatment for CGCL. However, conservative pharmacological treatment has been described as relevant for preoperative lesion reduction and decreased surgical morbidity. Intralesional corticosteroids are reported as a low-cost and minimally invasive alternative, particularly for non-aggressive lesions. Calcitonin is described as an option for both aggressive and non-aggressive lesions, although it requires prolonged therapy. Denosumab has been associated with rapid responses in highly aggressive, recurrent, or surgically challenging lesions, potentially favoring less extensive surgical procedures; however, the possibility of persistence of residual cells requires careful surgical planning. Interferon-alpha is indicated for aggressive and vascularized lesions, but its use is limited by adverse effects. CONCLUSION: Conservative pharmacological treatment represents a relevant and individualized strategy to reduce morbidity, preserve anatomical structures, and assist in the surgical planning of CGCL. " quero que deixe separado por tópicos para colar no banner e crie elementos visuais para colocar no resultados
Language: English
Subfield: Oral Surgery
Field: Dentistry
Open Access status: green
OpenAlex ID: W7201845833
Cites:
Cited by:
Related to: 10